Clinical Study: Type 1 Diabetes (T1D)

TrialNet Diabetes Risk Screening is available and free to eligible family members of people with type 1 diabetes through an international research effort and BRI.

PI: Carla J Greenbaum, MD

Email: Diabetes@BenaroyaResearch.org

Phone: 800.888.4187

Study Summary

Pathway to Prevention screening is the first step for all TrialNet prevention studies. Screening is free, quick, convenient and super important. Only a small blood sample is needed.

This unique screening can identify the early stages of type 1 diabetes (T1D) years before any symptoms appear. It also helps researchers learn more about how T1D develops and plan new studies exploring ways to prevent it. 

The study is divided into two parts: Screening and Monitoring. If the Screening blood tests show that you have autoantibodies, we will invite you to participate in the Monitoring portion of the study.

Eligibility Criteria

The following people may be eligible:

• Individuals who are 2-45 years of age with a parent, child, brother or sister with type 1 diabetes
• Individual who are 2-20 years of age with a niece, nephew, aunt, uncle, grandparent, half-sibling or cousin with type 1 diabetes
• Individuals age 2-45 years that have tested positive for at least one T1D related autoantibody outside of TrialNet
• Limited rescreening is available for those under age 18.

For more information visit TrialNet's Pathway to Prevention Study